Hello readers! Welcome to the updated Binaytara Foundation news page. Here, we will be providing updates and highlights from our recent events and global efforts, shed light on important issues, and give shout-outs to our incredible supporters. If you would like to learn more about the foundation or get involved, please visit www.binayfoundation.org. You can also find us on Twitter, Facebook, and LinkedIn. Thanks for visiting!
Binaytara Foundation held its Management of Multiple Myeloma: Clinical Updates from ASH20 conference on March 20th, 2021 through Zoom video conferencing. This meeting drew 40 participants, half of who were physicians, and the other half comprised of registered nurses, pharmacists, researchers, residents, and students. We had global participants from Germany, India, and Spain.
“I think BTF conferences stand out for their ease of engagement, high-quality faculty and presentations, and clinically meaningful information,” Dr. Andrew Cowan, an Associate Professor of Medicine at the University of Washington, medical oncologist at Seattle Cancer Care Alliance, and moderator for this meeting, shares.
Binaytara Foundation held its Molecular Therapeutics in Non-Small Cell Lunger Cancer conference on February 28, 2021, via Zoom video conferencing. The program saw a turnout of 88 attendees, a majority of who came from the United States.
“I believe that the conference was a good review of the many recent developments in non-small cell lung cancer, and we discussed several recent trials which are turning out to be practice-changing,” Dr. Joseph Rosales, a medical-oncologist from Virginia Mason Franciscan Health and the moderator for this event, shares.
Dr. Rosales was involved in creating the curricula for this meeting. The goal of…
We want to thank Sriyansh Shah, a sophomore at Centennial High School, whose Facebook fundraiser collected $2530 for Binaytara Foundation Cancer Center!
Sriyansh was introduced to the foundation through his dad, and he got interested in raising funds after discovering how many women die in Nepal due to improper cancer care. The most common female cancer in Nepal is cervical, which can be attributed to a lack of preventive measures and insufficient education on human papillomavirus (HPV). Breast cancer is the second most common, which is also typically diagnosed late-stage, creating a large burden on the health care system.
One of Binaytara Foundation’s (BTF) goals is to provide medical professionals opportunities to share, collaborate, and grow, and we accomplish this through our globally attended conferences. We have been organizing hematology-oncology conferences for the last 10 years. While the COVID-19 pandemic has halted in-person meetings, it has also created an opportunity for us to create more accessible, frequent virtual events. We took on this challenge by starting a multi-part monthly series where we present updates in the diagnosis, treatment, and management of various cancers through lectures and discussions with experts from all over the US and abroad.
Dr. Brahman Konda at the Binaytara Foundation Cancer Center in Nepal (third-person from the left)
Dr. Brahma Konda, a semi-retired hematologist-oncologist, got involved with the foundation a few years ago, when he and Dr. Binay Shah, the co-founder and president of Binaytara Foundation (BTF), used to work together in Bellingham, WA. He traveled to Nepal in January 2020 to volunteer at the Binaytara Foundation Cancer Center in Janakpur.
“I see a lot of value in teaching. I believe that is most important for me at this time of my career. I can only see 10 patients in a day, but…
March brings for a needed reminder of kidney cancer’s impact. In 2020, renal cell carcinoma (RCC) impacted 75,000 people, of which 14,000 died. However, there is rapid and innovative progress in understanding this cancer’s biology, as well as improved diagnostics and treatments.
We are a non-profit dedicated to improve cancer care globally through education, advocacy, and innovative programs